PASCAL OWUSU-AGYEMANG to Combined Modality Therapy
This is a "connection" page, showing publications PASCAL OWUSU-AGYEMANG has written about Combined Modality Therapy.
Connection Strength
0.387
-
Assessment of nephrotoxicity associated with combined cisplatin and mitomycin C usage in laparoscopic hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2019; 36(1):493-498.
Score: 0.072
-
Assessing the impact of perioperative blood transfusions on the survival of adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal carcinomatosis. Vox Sang. 2017 Aug; 112(6):567-577.
Score: 0.063
-
Assessing the survival impact of perioperative opioid consumption in children and adolescents undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Paediatr Anaesth. 2017 Jun; 27(6):648-656.
Score: 0.063
-
Anaesthetic techniques for unique cancer surgery procedures. Best Pract Res Clin Anaesthesiol. 2013 Dec; 27(4):513-26.
Score: 0.049
-
Safety of epidural analgesia in the perioperative care of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014 May; 21(5):1487-93.
Score: 0.049
-
Anesthetic management and renal function in pediatric patients undergoing cytoreductive surgery with continuous hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin. Ann Surg Oncol. 2012 Aug; 19(8):2652-6.
Score: 0.044
-
Risk of Intraoperative Hyperthermia and Outcomes in Adults Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol. 2022 Mar; 29(3):2089-2099.
Score: 0.021
-
Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for children, adolescents, and young adults: the first 50 cases. Ann Surg Oncol. 2015 May; 22(5):1726-32.
Score: 0.013
-
Complete cytoreduction and HIPEC improves survival in desmoplastic small round cell tumor. Ann Surg Oncol. 2014 Jan; 21(1):220-4.
Score: 0.012